A Win For AnPac Bio-Medical Science Co., Ltd.

AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ) soared at $5.7, representing a gain of 35.1%. On Fri 11 Dec 20, ANPC:NASDAQ hit a New 2-Week Low of $4.22. The stock appeared on our News Catalysts scanner on Mon 14 Dec 20 at 10:09 AM in the 'BIOTECH' category. From Fri 27 Nov 20, the stock recorded 30.00% Up Days and 36.36% Green Days

The stock spiked on Wed 25 Nov 20 at $8.48 with a volume of 40M+.

About AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ)

AnPac Bio-Medical Science Co Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative, patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated potential to assist physicians in cancer diagnosis, prognosis and recurrence.